Status:
COMPLETED
Juice Plus+OMEGA Study
Lead Sponsor:
Green Beat
Collaborating Sponsors:
Medical University of Graz
Conditions:
Healthy
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
In this randomized, controlled clinical study firstly the bioavailability of fatty acids and micronutrients of JP+® Omega Blend will be analysed. Secondly, the effect of the constituents contained in ...
Detailed Description
In this randomized, controlled clinical study firstly the bioavailability of fatty acids and micronutrients of JP+Omega Blend will be analysed. Secondly, the effect of the constituents contained in th...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 80 healthy men and women, 20-65 years
- suboptimal serum lipid values without medication
- triglycerides \>140 mg/dl
- HDL Chol \< 45 (m) or \< 50 mg/dl (w)
- Non smokers
- BMI \>20 and \<35 kg/m2
- ω-3-fatty acid index (ω-3 index): rank 21 - 100 of the ranking or ω-3 index \< 8%
- normal nutrition (omnivore diet)
- adherence to the 4-week long wash-out period
- Exclusion criteria:
- all people not meeting the inclusion criterions
- hypertension (systolic blood pressure \> 160mmHg, diastolic blood pressure \>100 mmHg)
- Specific diets and nutritional habits (vegan, vegetarian, paleo, low-carb pregnancy)
- aversion to stop the intake of nutritional supplements and food, that could interfere with the study outcome
- over-consumption of fish (\> 1 portion/week)
- linseed and walnut oil, whole linseeds and walnuts (\>1 portion (25g)/day)
- with omega-3 fatty acids enriched "functional food
- intake of lipid-lowering, anti-inflammatory, blood pressure lowering medication and anticoagulants
- clinically relevant infectious disease
- acute and chronic inflammatory disease
- Diabetes mellitus type I and type II
- supplementation of antioxidants in all variations, omega-3 fatty acids, plant extracts/concentrates
Exclusion
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 3 2020
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT03348553
Start Date
September 1 2017
End Date
February 3 2020
Last Update
August 6 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Pathophysiology and Immunology
Graz, Styria, Austria, 8010
2
Green Beat
Graz, Austria, 8042